How to Get Adderall XR in Maryland: Prescriptions, Telehealth, and Pharmacies

What Adderall XR Is and Why It Requires Special Handling in Maryland

Adderall XR is an oral extended-release capsule containing a 75/25 ratio of dextroamphetamine to levoamphetamine salts approved by the FDA for attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 and older, and for narcolepsy in adults [1]. Maryland follows the federal Controlled Substances Act classification of mixed amphetamine salts as Schedule II, placing it alongside oxycodone and methylphenidate in the highest controlled tier that still permits outpatient prescribing.

Schedule II status creates concrete procedural requirements. No refills are permitted on a single prescription. Each calendar month the patient needs a new written or electronic prescription. Maryland participates in the Prescription Drug Monitoring Program (PDMP), called CRISP (Chesapeake Regional Information System for our Patients), and every licensed prescriber must query CRISP before issuing a Schedule II script to a new patient. Pharmacies must report dispensing within 24 hours.

Clinically, the stimulant class has the strongest evidence base of any ADHD intervention. The landmark Multimodal Treatment Study of Children with ADHD (MTA, N=579) found that 56% of children assigned to medication management showed normalized teacher-rated behavior scores, compared with 25% in the community-care comparison group [2]. Adults carry a similar evidence profile: a 2017 meta-analysis in Lancet Psychiatry (N=10,068 across 133 trials) ranked amphetamine compounds among the most effective pharmacologic options for adult ADHD by standardized mean difference [3].

Who Can Prescribe Adderall XR in Maryland

Any Maryland-licensed prescriber with DEA Schedule II authority may write an Adderall XR prescription. That includes physicians (MD, DO), nurse practitioners (CRNP) with full prescriptive authority under Maryland's 2015 APRN autonomy law, and physician assistants (PA-C) practicing within a supervision agreement that explicitly covers Schedule II substances.

Maryland grants CRNPs independent prescribing authority after 18 months of post-graduate clinical experience, so many telehealth platforms operating in the state staff NPs who can diagnose ADHD and initiate stimulant therapy without a physician co-signature. Psychiatrists, adult and pediatric, are the most common specialists, but primary care physicians and some internal medicine providers also prescribe routinely for adult ADHD.

Psychologists (PhD, PsyD) and licensed clinical social workers (LCSW) cannot prescribe in Maryland. They provide invaluable diagnostic support through neuropsychological testing, but the actual DEA-numbered prescription must come from an MD, DO, CRNP, or PA-C.

One practical note: some primary care practices maintain informal policies against initiating new stimulant prescriptions and will refer patients to psychiatry. If you encounter that, telehealth ADHD-specialty services are a direct alternative (see the telehealth section below).

How to Get a Diagnosis and Prescription: Step-by-Step

Getting Adderall XR legally in Maryland follows a defined sequence. The process is not arbitrary; each step exists because Schedule II misuse and diversion carry real clinical and legal consequences.

Step 1: Schedule a diagnostic evaluation. A licensed prescriber or a psychologist (for testing only) reviews your symptom history using DSM-5-TR criteria for ADHD. The DSM-5-TR requires at least five inattentive or hyperactive-impulsive symptoms, present in two or more settings, with impairment tracing back to before age 12 [4]. Providers typically use validated rating scales such as the Adult ADHD Self-Report Scale (ASRS) or the Conners' Adult ADHD Rating Scales (CAARS).

Step 2: CRISP query. Before issuing the prescription, the provider checks your CRISP history. If you have active Schedule II prescriptions from another provider, expect a direct conversation before anything is sent to the pharmacy.

Step 3: New prescription to pharmacy. Maryland accepts both paper Schedule II prescriptions and Electronic Prescribing of Controlled Substances (EPCS), which is now the default method for most telehealth platforms. The script may not carry refills.

Step 4: Pharmacy verification and dispensing. The pharmacist independently verifies your identity and the prescriber's DEA registration. Depending on current drug supply, filling may require calling ahead to multiple pharmacies (see the pharmacy section below).

Step 5: Monthly follow-up. Most prescribers schedule 15 to 30-minute check-ins monthly or every two months to reassess symptom control, heart rate, blood pressure, sleep, appetite, and any cardiovascular concerns before authorizing the next prescription.

Labs and Workup Before Starting Adderall XR

No universal national guideline mandates specific lab panels before prescribing stimulants to otherwise healthy adults, but standard clinical practice in Maryland includes several assessments.

Blood pressure and resting heart rate are measured at every visit because amphetamines produce average systolic blood pressure increases of 2 to 4 mmHg and resting heart rate increases of 3 to 6 bpm, according to the Adderall XR prescribing label [1]. Patients with uncontrolled hypertension (systolic above 180 mmHg or diastolic above 110 mmHg) are generally not started on stimulants until their cardiovascular status is stable.

A personal and family history of structural cardiac abnormalities, arrhythmias, or sudden unexplained death is documented before prescribing. The FDA label carries a black-box warning for cardiovascular events and a warning for serious psychiatric adverse effects [1]. An ECG is not required by any current U.S. guideline for otherwise healthy patients, though individual providers may order one based on clinical judgment.

Basic metabolic panel and thyroid-stimulating hormone (TSH) are sometimes ordered to rule out hyperthyroidism or electrolyte disturbances that mimic ADHD symptoms or could exacerbate stimulant side effects. Pregnancy testing is not required by label but is standard practice for patients of childbearing potential, given that amphetamines carry FDA Pregnancy Category C (potential fetal risk) status.

Weight and BMI are documented at baseline because appetite suppression is dose-dependent and monitoring weight trajectories matters especially in pediatric patients.

Telehealth Options for Adderall XR in Maryland

Maryland law explicitly permits telehealth prescribing of Schedule II controlled substances for established patients following a full clinical encounter. Since the DEA's temporary COVID-era rule extensions, telehealth initiation of stimulants requires either a prior in-person visit or a full synchronous audio-video encounter that satisfies the Ryan Haight Act's definition of a "valid prescription" [5].

As of mid-2025, Maryland's Board of Physicians continues to allow audio-video telemedicine as an acceptable setting for Schedule II initiation, provided the prescriber holds a Maryland DEA registration and the patient is physically located in Maryland at the time of the visit. Text-only or asynchronous encounters are not sufficient for a Schedule II prescription under federal rules.

Several national ADHD-specialty telehealth platforms (Done, Cerebral, Ahead, and others) hold Maryland licensure and can initiate Adderall XR after a synchronous video evaluation. Typical turnaround from booking to prescription: 48 to 96 hours for an initial appointment, then electronic prescription sent same day. HealthRX's own clinical team includes Maryland-licensed providers who conduct full ADHD evaluations via video and, when clinically appropriate, prescribe mixed amphetamine salts directly through Maryland-registered pharmacies.

Insurance coverage for telehealth ADHD visits varies. Maryland's 2019 telehealth parity law requires commercial insurers to reimburse telehealth visits at the same rate as in-person encounters when the service itself is covered, but it does not mandate that all ADHD services be covered [6]. Patients on Maryland Medicaid (HealthChoice) should verify coverage with their managed care organization before booking.

Getting Adderall XR at Maryland Pharmacies

The FDA-approved brand Adderall XR is manufactured by Teva; multiple generic versions of mixed amphetamine salts extended-release are on the market. During periods of national shortage (the FDA first documented the shortage in October 2022 and sporadic supply disruptions have continued), Maryland pharmacies may have inconsistent stock.

Practical steps that reduce wait times:

Call ahead with the exact strength you need. Maryland CVS, Walgreens, Rite Aid, and independent pharmacies all carry the drug, but stock varies by location and week. Most pharmacists will tell you over the phone whether they have the quantity on hand.

Ask your prescriber about writing for a different manufacturer if your preferred one is out. Generic mixed amphetamine salts from Amneal, Lannett, or Mallinckrodt are therapeutically equivalent to brand Adderall XR under FDA bioequivalence standards, though some patients report subjective differences between manufacturers [7].

GoodRx and Mark Cuban's Cost Plus Drugs (costplusdrugs.com) list real-time cash prices. As of early 2025, generic 30-count bottles of 20 mg mixed amphetamine salts ER range from approximately $35 to $80 cash price depending on pharmacy.

503A compounding in Maryland: Licensed 503A compounding pharmacies in Maryland may prepare mixed amphetamine salts in custom doses or formulations (such as a liquid suspension for patients who cannot swallow capsules) when a valid prescription from a Maryland-licensed prescriber specifies a clinical need for the compounded preparation. The FDA does not regulate 503A compounders directly, but the Maryland Board of Pharmacy oversees their licensure. Compounded Schedule II products follow the same prescription rules as commercially manufactured ones: no refills, CRISP reporting, DEA number required.

Maryland Medicaid Prior Authorization for Adderall XR

Maryland Medicaid (HealthChoice) covers Adderall XR for ADHD and narcolepsy, but prior authorization is required before the pharmacy will dispense. The PA process typically asks for:

Documentation of the DSM-5-TR ADHD diagnosis with symptom onset before age 12 and impairment in two or more settings. A list of any prior stimulant trials and outcomes (prescribers should document at least one trial of a first-line generic before brand Adderall XR is approved, though many plans accept the diagnosis alone for generic mixed amphetamine salts). The prescribing provider's Maryland license number, DEA number, and NPI. For pediatric patients, school records or teacher rating scales often strengthen the PA submission.

The Maryland Department of Health's Medicaid preferred drug list (PDL) typically lists generic mixed amphetamine salts (immediate-release and extended-release) in a preferred tier, meaning generics may not require PA at all [8]. Brand Adderall XR, being non-preferred, almost always requires PA. Turnaround on PA decisions runs 2 to 5 business days under Maryland Medicaid rules; urgent PA requests must be answered within 24 hours.

If PA is denied, prescribers may file an appeal using the Medicaid fair-hearing process or pivot to an alternative generic formulation that sits in the preferred tier.

Transferring an Adderall XR Prescription to Maryland

Transferring a Schedule II prescription across state lines is not permitted under the DEA Controlled Substances Act [9]. A pharmacist in Virginia cannot send your Adderall XR prescription to a Maryland pharmacy. The solution is straightforward: your prescriber sends a new, Maryland-compliant electronic or paper prescription directly to the Maryland pharmacy of your choice.

Within Maryland, a filled but partially dispensed Schedule II prescription cannot be transferred between pharmacies either, per 21 U.S.C. 827 and Maryland COMAR 10.34.17. If your pharmacy cannot fill the full quantity, ask them to fill what they have and have your prescriber issue a new script to a second pharmacy for the remainder, or wait for restocking.

For patients relocating to Maryland from another state: your out-of-state prescriber's existing prescription is not valid at a Maryland pharmacy. Schedule an appointment with a Maryland-licensed prescriber before your supply runs out. Telehealth services with Maryland licensure can often see new patients within one to two weeks and bridge that gap without an in-person office visit.

Dose Titration and What to Expect Clinically

The FDA-approved adult starting dose in the Adderall XR label is 20 mg once daily in the morning; some prescribers begin at 10 mg to reduce side-effect burden, then titrate upward at weekly intervals [1]. The maximum labeled dose for adults is 60 mg per day, though most clinical practice stays below 40 mg.

Common initial side effects include appetite suppression (reported in up to 22% of adults in registration trials), insomnia (up to 27%), and dry mouth. These often diminish after two to four weeks as patients adjust. Taking the dose immediately after a protein-containing breakfast can reduce appetite suppression by blunting the sharp early plasma peak.

The extended-release bead formulation produces two plasma peaks: one at approximately 1.5 hours and a second at approximately 6 to 7 hours after ingestion. This biphasic profile provides roughly 8 to 10 hours of clinical effect. Patients who need coverage into the evening may discuss an afternoon booster of immediate-release mixed amphetamine salts with their prescriber rather than increasing the XR dose.

Blood pressure should be rechecked at every prescription renewal visit. The American Heart Association's 2008 scientific statement on cardiovascular monitoring in children receiving stimulants (ADHD medications) recommends baseline and follow-up blood pressure and heart rate at each visit [10]. The same standard applies in adult practice. Patients with resting systolic blood pressure above 150 mmHg at follow-up should have their dose reassessed before refilling.

Frequently Asked Questions